About Maclan Pharma
Maclan Pharma produces high-quality pharmaceutical products for various therapeutic areas through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and therapeutic products. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarter Jaipur, India
- SectorsHealthcare
- Website maclanpharma.com
- Legal Name Maclan Pharmaceuticals Private Limited
- Date of Incorporation 20 Sep, 2010
- Jurisdiction Jaipur, Rajasthan, India
- Annual Revenue₹3.34 Cr
FY 2025 · +9% YoY
- Net Profit₹5 Lakh
FY 2025 · 1% margin
- EBITDA₹9.6 Lakh
FY 2025 · 3% margin
Associated legal entities of Maclan Pharma
Maclan Pharma operates through Maclan Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Maclan Pharmaceuticals Private Limited CIN U24232RJ2010PTC032899 | Active | 20 Sep 2010 | Jaipur, Rajasthan | ₹3.3 Cr | – | 2 | View details |
Board of directors of Maclan Pharmaceuticals Private Limited (Maclan Pharma)
Maclan Pharmaceuticals Private Limited is the primary company behind Maclan Pharma. The board of Maclan Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Anshul Chaturvedi, appointed in 2010. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anshul Chaturvedi DIN 03151712 | Director | 20 Sep 2010 | 16 yrs | Maclan Pharmaceuticals Private Limited |
| Pratibha Ojha DIN 05283328 | Director | 24 Apr 2012 | 14 yrs 5 mo | Maclan Pharmaceuticals Private Limited |
Financials of Maclan Pharma
Figures of Maclan Pharmaceuticals Private Limited, the primary company behind Maclan Pharma, for FY 2025. Revenue was ₹3.34 Cr (+9% year on year). Net profit was ₹5 Lakh (1% margin). EBITDA was ₹9.6 Lakh (3% margin). Revenue has grown at a compounded annual rate of +11% over three years and +8% over five years.
- ₹3.34 CrRevenue · FY 2025 · +9% YoY
- ₹5 LakhNet profit · 1% margin
- ₹9.6 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- +11%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Maclan Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Maclan Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Maclan Pharma
10 companies that operate in the same segment as Maclan Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Maclan Pharma
Maclan Pharma was founded in 2010.
Maclan Pharma is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
The primary company behind Maclan Pharma, Maclan Pharmaceuticals Private Limited, reported revenue of ₹3.34 Cr for FY 2025, up 9% year on year.
Maclan Pharma produces high-quality pharmaceutical products for various therapeutic areas through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and therapeutic products. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Maclan Pharma operates through Maclan Pharmaceuticals Private Limited.
The legal entities of Maclan Pharma currently have 2 directors, including Anshul Chaturvedi, Pratibha Ojha.